Phosphospecific antibodies reveal temporal regulation of platelet- derived growth factor β receptor signaling

Experimental Cell Research

Volumn 253, Issue 2, 1999, Pages 704-712

  Bernard, Amy ^a,b   Kazlauskas, Andrius ^a  

^a SCHEPENS EYE RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

PDGF; Phosphorylation specificity; Phosphospecific antibodies; Platelet derived growth factor receptor; Receptor tyrosine kinase; Temporal regulation

Indexed keywords

PLATELET DERIVED GROWTH FACTOR B; PLATELET DERIVED GROWTH FACTOR RECEPTOR;

ANIMAL CELL; ANTIBODY SPECIFICITY; ARTICLE; CELL DIFFERENTIATION; CELL GROWTH; EMBRYO; GROWTH REGULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

EID: 0033572905     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.1999.4715     Document Type: Article

References (32)

1. Raines E. W., Bowen-Pope D. F., Ross R. Peptide growth factors and their receptors. Sporn M. B., Roberts A. B. Handbook of Experimental Pharmacology. 1991;Springer-Verlag, New York.
2. Ross R., Raines E. W., Bowen-Pope D. F. The biology of platelet-derived growth factor. Cell. 46:1986;155-169.
3. Holmgren L., Glaser A., Pfeifer-Ohlsson S., Ohlsson R. Angiogenesis during human extraembryonic development involves the spatiotemporal control of PDGF ligand and receptor gene expression. Development. 113:1991;749-754.
4. Floege J., Eng E., Young B. A., Alpers C. E., Barrett T. B., Bowen-Pope D. F., Johnson R. J. Infusion of platelet-derived growth factor or basic fibroblast growth factor induces selective glomerular mesangial cell proliferation and matrix accumulation in rats. J. Clin. Invest. 92:1993;2952-2962.
5. Heldin C.-H., Östman A., Rönnstrand L. Signal transduction via platelet-derived growth factor receptors. Biochim. Biophys. Acta. 1378:1998;F79-F113.
6. Kazlauskas A. Receptor tyrosine kinases and their targets. Curr. Opin. Genet. Dev. 4:1994;5-14.
7. Kazlauskas A., Cooper J. A. Autophosphorylation of the PDGF receptor in the kinase insert region regulates interactions with cell proteins. Cell. 58:1989;1121-1133.
8. Kashishian A., Kazlauskas A., Cooper J. A. Phosphorylation sites in the PDGF receptor with different specificities for binding GAP and PI3 kinase in vivo. EMBO J. 11:1992;1373-1382.
9. Jones S. M., Klinghoffer R., Prestwich G. D., Toker A., Kazlauskas A. A wave of phosphoinositide 3-kinase activity in mid G1 is essential for PDGF-dependent DNA synthesis. Curr. Biol. 9:1999;512-521.
10. Taylor S. J., Shalloway D. Cell cycle-dependent activation of Ras. Curr. Biol. 6:1996;1621-1627.
11. Segal R. A., Bhattacharyya A., Rua L. A., Alberta J. A., Stephens R. M., Kaplan D. R., Stiles C. D. Differential utilization of Trk autophosphorylation sites. J. Biol. Chem. 271:1996;20175-20181.
12. Valius M., Kazlauskas A. Phospholipase C-γ1 and phosphatidylinositol 3 kinase are the downstream mediators of the PDGF receptor's mitogenic signal. Cell. 73:1993;321-334.
13. Baxter R., Secrist J. P., Vaillancourt R., Kazlauskas A. Full activation of the Platelet-Derived Growth Factor β-receptor kinase involves multiple events. J. Biol. Chem. 273:1998;17050-17055.
14. Ory D. S., Neugeboren B. A., Mulligan R. C. A stable human-derived packaging cell line for production of high titer retrovirus/vesicular stomatitis virus G Pseudotypes. Proc. Natl. Acad. Sci. USA. 93:1996;11400-11406.
15. Valius M., Bazenet C., Kazlauskas A. Tyrosines 1021 and 1009 are phosphorylation sites in the carboxy terminus of the platelet-derived growth factor receptor β subunit and are required for binding of phospholipase Cγ and a 64-kilodalton protein, respectively. Mol. Cell. Biol. 13:1993;133-143.
16. Hart C. E., Seifert R. A., Bowen-Pope D. F. Synthesis, phosphorylation and degradation of multiple forms of the platelet-derived growth factor receptor studied using a monoclonal antibody. J. Biol. Chem. 262:1987;10780-10785.
17. Kazlauskas A., Kashishian A., Cooper J. A., Valius M. GTPase-activating protein and phosphatidylinositol 3-kinase bind to distinct regions of the platelet-derived growth factor receptor β subunit. Mol. Cell. Biol. 12:1992;2534-2544.
18. Epstein R. J., Druker B. J., Roberts T. M., Stiles C. D. Synthetic phosphopeptide immunogens yield activation-specific antibodies to the c-erbB-2 receptor. Proc. Natl. Acad. Sci. USA. 89:1992;10435-10439.
19. erbB-2 and the epidermal growth factor receptor. Proc. Natl. Acad. Sci. USA. 89:1992;11637-11641.
20. Bazenet C. E., Gelderloos J. A., Kazlauskas A. Phosphorylation of tyrosine 720 in the platelet-derived growth factor alpha receptor is required for binding of Grb2 and SHP-2 but not for activation of Ras or cell proliferation. Mol. Cell. Biol. 16:1996;6926-6936.
21. Harlow E., Lane D. Antibodies: A Laboratory Manual. 1988;Cold Spring Harbor Laboratory, Cold Spring Harbor.
22. Joly M., Kazlauskas A., Fay F. S., Corvera S. Disruption of PDGF receptor trafficking by mutation of its PI-3 kinase binding sites. Science. 263:1994;684-687.
23. Shamah S. M., Alberta J. A., Giannobile W. V., Guha A., Kwon Y. K., Carroll R. S., Black P. M., Stiles C. D. Detection of activated platelet-derived growth factor receptors in human meningioma. Cancer Res. 57:1997;4141-4147.
24. Sorkin A., Westermark B., Heldin C.-H., Claesson-Welsh L. Effect of receptor kinase inactivation on the rate of internalization and degradation of PDGF and the PDGF β-receptor. J. Cell. Biol. 3:1991;469-478.
25. Bazenet C., Kazlauskas A. The PDGF receptor alpha subunit activates p21ras and triggers DNA synthesis without interacting with RasGAP. Oncogene. 9:1994;517-525.
26. Klinghoffer R. A., Kazlauskas A. Identification of a putative Syp substrate, the PDGF beta receptor. J. Biol. Chem. 270:1995;22208-22217.
27. Cirri P., Chiarugi P., Taddei L., Raugei G., Camici G., Manao G., Ramponi G. Low molecular weight protein-tyrosine phosphatase tyrosine phosphorylation by c-Src during platelet-derived growth factor-induced mitogenesis correlates with its subcellular targeting. J. Biol. Chem. 273:1998;32522-32527.
28. Panayotou G., Gish G., End P., Truong O., Gout I., Dhand R., Fry M. J., Hiles I., Pawson T., Waterfield M. D. Interactions between SH2 domains and tyrosine-phosphorylated platelet-derived growth factor β-receptor sequences: Analysis of kinetic parameters by a novel biosensor-based approach. Mol. Cell. Biol. 13:1993;3567-3576.
29. Liu P., Ying Y., Ko Y.-G., Anderson R. G. Localization of platelet-derived growth factor-stimulated phosphorylation cascade to caveolae. J. Biol. Chem. 17:1996;10299-10303.
30. Yamamoto M., Toya Y., Jensen R. A., Ishikawa Y. Caveolin is an inhibitor of platelet-derived growth factor receptor signaling. Exp. Cell. Res. 247:1999;380-388.
31. Rosenfeld M. E., Bowen-Pope D. F., Ross R. Platelet-derived growth factor: morphologic and biochemical studies of binding, internalization, and degradation. J. Cell. Physiol. 121:1984;263-274.
32. Nilsson J., Thyberg J., Heldin C.-H., Westermark B., Wasteson A. Surface binding and internalization of platelet-derived growth factor in human fibroblasts. Proc. Natl. Acad. Sci. USA. 80:1983;5592-5596.